Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |